You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
尖峯集團(600668.SH):子公司尖峯亦恩“JFAN-1001 膠囊”獲批臨牀試驗
格隆匯 08-19 16:38

格隆匯 8 月 19日丨尖峯集團(600668.SH)發佈公告,近日,公司控股子公司浙江尖峯藥業有限公司的控股子公司浙江尖峯亦恩生物科技有限公司(以下簡稱“尖峯亦恩”),收到國家食品藥品監督管理局核准簽發的《藥物臨牀試驗批准通知書》,“JFAN-1001膠囊,通知書編號:2020LP00246”和“JFAN-1001膠囊,通知書編號:2020LP00247”。

公司本次獲得藥物臨牀試驗批准通知書,對公司近期經營業績不會產生重大影響。由於藥物研發的特殊性,藥品的前期研發以及產品從研製、臨牀試驗到投產的週期長、環節多,容易受到一些不確定性因素的影響,臨牀試驗進度、結果以及未來產品市場競爭形勢均存在諸多不確定性。本公司將根據研發進展情況及時履行信息披露義務,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account